Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers

2009 ◽  
Vol 60 (6) ◽  
pp. 508-514 ◽  
Author(s):  
K. Kurz ◽  
T. Teerlink ◽  
M. Sarcletti ◽  
G. Weiss ◽  
R. Zangerle ◽  
...  
Keyword(s):  
Risk Factor ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factor ◽  
Immune Activation ◽  
Asymmetric Dimethylarginine ◽  
Plasma Concentrations ◽  
Activation Markers ◽  
Hiv 1

scholarly journals Asymmetric Dimethylarginine: A Novel Cardiovascular Risk Factor in End-Stage Renal Disease

2012 ◽  
Vol 40 (1) ◽  
pp. 340-349 ◽  
Author(s):  
M Yusuf Alsagaff ◽  
M Thaha ◽  
M Aminuddin ◽  
RM Yogiarto ◽  
M Yogiantoro ◽  
...  
Keyword(s):  
Risk Factor ◽  
Cardiovascular Risk ◽  
Renal Disease ◽  
Cardiovascular Risk Factor ◽  
End Stage Renal Disease ◽  
Asymmetric Dimethylarginine ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Asymmetric dimethylarginine in patients with rheumatological diseases: a non-classical cardiovascular risk factor?

2020 ◽  
Vol 25 (5) ◽  
pp. 510-519
Author(s):  
E. P. Kolesova ◽  
A. L. Maslyansky ◽  
O. P. Rotar ◽  
I. N. Grigorieva ◽  
I. N. Penin ◽  
...  
Keyword(s):  
Risk Factor ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factor ◽  
Asymmetric Dimethylarginine ◽  
Rheumatological Diseases
Sign in / Sign up

Export Citation Format

Share Document